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Abstract 
Infantile digital fibromatosis (IDF) is a rare
benign fibroproliferative tumor of early child-
hood. IDF preferentially affects the fingers and
the toes. Malignant transformation or metas-
tases have never been reported. Surgical treat-
ment has been advocated previously but local
recurrences were observed frequently. Recent
literature supports clinical surveillance with-
out  any  medical  or  surgical  intervention  as
spontaneous  regression  usually  occurs  after
two to three years. A six-month-old Caucasian
girl with IDF on the left fourth digit is present-
ed here. The tumor progressively increased in
size after birth. Topical imiquimod cream and
diflucortolone valerate cream, both displaying
antifibrotic properties, had no effect on tumor
growth. Currently the lesion size remains sta-
ble without any treatment. Early recognition of
IDF is important in order to avoid unnecessary
surgical  intervention  that  may  prove  to  be
potentially  aggravating,  unless  serious  func-
tional or cosmetic concerns intervene. Parents
should  be  reassured  concerning  the  benign
nature  of  IDF  and  be  informed  that  sponta-
neous involution of IDF might be expected.   
Introduction
Infantile digital fibromatosis (IDF) is a rare
benign tumor of fibromatous origin. IDF pref-
erentially occurs during early childhood and is
present at birth in about 30% of the cases.
1
Predilection sites include the distal phalanx of
the fingers and the toes. Initially IDF was con-
sidered as a potentially malignant tumor, lead-
ing to the amputation of the affected digits.
1-3
More recently several case reports of sponta-
neous regression suggest a benign biological
behavior.
3-5 Malignant  transformation  and
metastases  have  never  been  reported.
1-6
Histopathology  often  reveals  paranuclear
inclusion bodies within proliferating spindle-
form cells.
7Currently conservative treatment is
recommended according to the benign nature
of IDF, the tendency to spontaneous regression,
and the frequent recurrences after surgery.
6,8
Case Report
A  six-month-old  Caucasian  girl  presented
after birth with three reddish, confluent, small,
painless, indurated, ill-circumscribed nodules
on the fourth digit of the left hand, which pro-
gressively  increased  in  size  (Figure  1).
Previous  medical  history  was  unremarkable
and there was no history of trauma or inflam-
mation. No allergic history was reported. The
other hand and both feet were unremarkable.
None of the family members had experienced
similar  lesions.  There  was  no  functional
impairment and the size of the lesion did not
appear to bother the child in daily life. No signs
of  scratching  were  present.  Further  clinical
examination was normal and Rontgen exami-
nation  revealed  the  cutaneous  and  subcuta-
neous location of the lesion without further
bone or joint involvement. Six months later a
second  examination  showed  no  differences
and the developmental stage of the child was
normal according to age. 
A 3-mm punch biopsy was performed under
local  anesthesia,  and  the  histopathology
revealed a fibromatosis affecting the reticular
and adventitial dermis, arranged as sheets and
interlacing bundles of eosinophilic myofibrob-
lasts set in a collagenous background. Some
cells  demonstrated  eosinophilic  cytoplasmic
inclusions (Figure 2). No mitotic figures and
no atypical cells were observed. The overlying
epidermis was unremarkable. A final diagnosis
of congenital IDF was suggested. 
As the data in the current literature recom-
mend  avoiding  surgical  intervention,  non-
invasive  treatments  exhibiting  anti-fibrotic
properties  were  sought.  A  topical  treatment
with imiquimod cream (Aldara cream), applied
three times a week during four weeks, failed to
reduce the tumor size and was associated with
significant  skin  irritation,  forcing  the  inter-
ruption of the treatment. Subsequently topical
applications of diflucortolone valerate signifi-
cantly reduced the inflammation although no
effect on the lesion size was observed. Eight
months later the tumor size remained identi-
cal. As no functional concerns were revealed,
conservative management is being followed.
Discussion
IDF is a rare tumor usually affecting one or
more  digits.
1 Numerous  synonyms  describe
IDF, including Reye’s tumor,
9 multiple hyaline
fibromatosis,  infantile  dermal  fibromatosis,
subdermal  fibromatosis  tumor  of  infancy,
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Figure  1.  Infantile  digital  fibromatosis
affecting the fourth digit.
Figure 2. High-power histological presen-
tation  of  the  characteristic  perinuclear
cytoplasmic  cellular  inclusions  found  in
infantile  digital  fibromatosis.
(Hematoxylin and eosin stain).[Rare Tumors 2009; 1:e47] [page 147]
fibroma  durum  multiplex,  recurrent  digital
fibroma, and juvenile dermatofibroma. IDF typ-
ically develops during the first year of life and
the majority of cases are sporadic. Congenital
onset,  although  rare,  is  described  also,
7,10 as
observed in our patient. Occurrence of IDF in
adulthood has been reported only once in a 52-
year-old woman with a tumor on the dorsum of
the proximal nail fold of the right second toe.
11
Clinically  IDF  presents  as  smooth,  round,
indurate,  confluent  nodules  up  to  2  cm  in
diameter. The lesions are single or multiple.
7,8
The  color  is  pink  to  reddish.  Initially  IDF
exhibits an indolent progression followed by a
rapid  growth  phase  during  several  months.
Subsequently  the  tumor  size  remains  stable
until spontaneous regression without scarring
occurs.
8 IDF is painless and not pruritic. It is
localized  usually  on  the  lateral  and  dorsal
aspects of the fingers and/or toes sparing the
thumb and the great toe. Ulceration may occur.
Functional  impairments  or  deformities  are
rare.
Histopathology  reveals  a  proliferation  of
myofibroblasts often displaying characteristic
paranuclear  eosinophilic  inclusion  bodies.
1
They are juxtanuclear typically and sometimes
indent the nucleus.
6,7 Mitotic figures are rare.
Usually the tumor cells immunohistochemical-
ly express vimentin, calponin, desmin, and α-
smooth muscle actin, whereas results for ker-
atin and muscle actin are negative.
1 The posi-
tive  actin  staining  suggests  the  presence  of
contractile filaments. Masson trichrome histo-
chemical staining reveals a red staining and a
purple coloration with phosphotungstic acid-
hematoxylin. 
The etiology of IDF remains uncertain but
the following hypothesis is proposed currently.
The differentiation from fibroblasts to myofi-
broblasts is a cornerstone process in wound
healing and tissue repair. Myofibroblasts may
create high contractile forces that are benefi-
cial  for  physiological  tissue  remodeling  but
harmful for tissue function, especially when it
becomes  excessive  such  as  in  hypertrophic
scars, in nearly all fibrotic diseases, and during
stroma reactions to tumors.
12 The intracellular
inclusions suggest a viral origin. However, this
etiopathogenic hypothesis was invalidated as
human papillomavirus HPV DNA types 6, 11,
16, and 18, and herpes simplex virus DNA type
I and II could not be demonstrated in IDF.
13 IDF
may  be  associated  with  articular  alterations
and  dysfunction.
6,8,14 The  etiopathogenesis  of
IDF joint deformities is not clear. Given the
presence  of  contractile  proteins  within  the
pathological cells, as suggested by histochemi-
cal, immunohistochemical, and ultrastructural
studies, they may intervene in the progressive
contracture, especially when the tumor occurs
adjacent to a joint.
8
The differential diagnosis of IDF includes
keloids,  hypertrophic  scar  tissue,  terminal
osseous dysplasia and pigmentary defects, and
juvenile aponeurotic fibroma.
6 The diagnosis
is clinical essentially but histological confir-
mation confirms the diagnosis and prognosis.
The current management of IDF recommends
avoiding surgical intervention, as spontaneous
involution of IDF is the rule.
6 In fact, wide local
surgical excision has been associated with a
recurrence rate of up to 60%.
1-3 If required by
functional  impairment,  Mohs  micrographic
surgery is recommended.
11 An patient with IDF
was treated effectively by Mohs surgery with-
out  any  residual  functional  impairment  or
recurrence of the tumor.
15 However even Mohs
surgery  is  regularly  associated  with  recur-
rences.
12 Consequently  surgical  treatment
should be avoided unless severe dysfunction is
observed.  Several  medical  approaches  have
been evaluated. A 7-year-old boy was treated
successfully with five monthly injections of flu-
orouracil.
16 Topical  imiquimod,  an  imidazo-
quinoline  amine,  acts  as  a  toll-like  receptor
(TLR)  7  and  8  agonist  and  stimulates  the
innate  and  cell-mediated  immune  system
through  induction  of  interferon-α (IFN-α),
IFN-γ, and interleukin-1, 6, 8, and 12 produc-
tion. Beside the antiviral and antitumor prop-
erties, imiquimod also inhibits human fibro-
blast collagen production by INF-α and INF-γ.
17
Topical and intralesional corticosteroids also
display anti-fibrotic properties, and are used
for treating keloids and hypertrophic scars.
17
Despite these anti-fibrotic properties, our case
failed to respond to topical imiquimod therapy
and  was  associated  with  significant  adverse
events.  Topical  corticosteroid  applications
reduced only the inflammatory aspect of IDF
without reducing the lesion size. 
In conclusion, IDF is a rare benign child-
hood tumor, which is important to recognize to
avoid  unnecessary  surgery  unless  serious
functional concerns intervene. Parents should
be informed of the benign nature of IDF. This
represents a strong argument for a conserva-
tive  approach  until  spontaneous  involution
occurs.
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